Adage Capital Partners Gp, L.L.C. Atai Life Sciences N.V. Transaction History
Adage Capital Partners Gp, L.L.C.
- $59.7 Billion
- Q3 2025
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 5,434,782 shares of ATAI stock, worth $21.7 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
5,434,782
Previous 5,434,782
-0.0%
Holding current value
$21.7 Million
Previous $11.9 Million
141.55%
% of portfolio
0.05%
Previous 0.02%
Shares
1 transactions
Others Institutions Holding ATAI
# of Institutions
149Shares Held
45.8MCall Options Held
1.88MPut Options Held
543K-
Ubs Group Ag7.68MShares$30.7 Million0.01% of portfolio
-
Morgan Stanley New York, NY4.82MShares$19.3 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.58MShares$10.3 Million0.0% of portfolio
-
Ally Bridge Group (Ny) LLC New York, NY2.29MShares$9.15 Million12.47% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.02MShares$8.08 Million0.07% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $664M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...